Walton, Nathan I.
Gao, Zhe
Eygeris, Yulia
Ghandehari, Hamidreza
Zharov, Ilya https://orcid.org/0000-0002-6292-8440
Funding for this research was provided by:
National Institutes of Health (R01ES024681)
National Science Foundation (CHE-1710052)
Article History
Received: 3 November 2017
Accepted: 6 April 2018
First Online: 21 April 2018
Compliance with ethical standards
:
: H. Ghandehari is co-founder of Theratarget, LLC, a drug delivery company based in Salt Lake City, Utah. The authors declare that they have no conflict of interest.